202 related articles for article (PubMed ID: 20435039)
1. Leishmania major: in vitro and in vivo anti-leishmanial effect of cantharidin.
Ghaffarifar F
Exp Parasitol; 2010 Oct; 126(2):126-9. PubMed ID: 20435039
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis.
Nahrevanian H; Farahmand M; Aghighi Z; Assmar M; Amirkhani A
Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of anti-leishmanial activity by induction of nitric oxide and inhibition of prostaglandin in Balb/c mice infected with Leishmania major.
Nahrevanian H; Hajihosseini R; Arjmand M; Farahmand M; Ghasemi F
Southeast Asian J Trop Med Public Health; 2009 Nov; 40(6):1188-98. PubMed ID: 20578452
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo prophylactic and curative activity of the triterpene saponin PX-6518 against cutaneous Leishmania species.
Inocêncio da Luz RA; Vermeersch M; Deschacht M; Hendrickx S; Van Assche T; Cos P; Maes L
J Antimicrob Chemother; 2011 Feb; 66(2):350-3. PubMed ID: 21131319
[TBL] [Abstract][Full Text] [Related]
5. Determination of intracellular efficacies of azithromycin against Leishmania major infection in human neutrophils in vitro.
Tanyuksel M; Bas AL; Araz E; Aybay C
Cell Biochem Funct; 2003 Mar; 21(1):93-6. PubMed ID: 12579528
[TBL] [Abstract][Full Text] [Related]
6. Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens.
Aguiar MG; Silva DL; Nunan FA; Nunan EA; Fernandes AP; Ferreira LA
J Antimicrob Chemother; 2009 Dec; 64(6):1234-40. PubMed ID: 19825819
[TBL] [Abstract][Full Text] [Related]
7. Neolignan Licarin A presents effect against Leishmania (Leishmania) major associated with immunomodulation in vitro.
Néris PL; Caldas JP; Rodrigues YK; Amorim FM; Leite JA; Rodrigues-Mascarenhas S; Barbosa-Filho JM; Rodrigues LC; Oliveira MR
Exp Parasitol; 2013 Oct; 135(2):307-13. PubMed ID: 23891943
[TBL] [Abstract][Full Text] [Related]
8. S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.
Costa IS; de Souza GF; de Oliveira MG; Abrahamsohn Ide A
J Antimicrob Chemother; 2013 Nov; 68(11):2561-8. PubMed ID: 23788476
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of peritoneal macrophage phagocytic activity against Leishmania major by garlic (Allium sativum) treatment.
Ghazanfari T; Hassan ZM; Khamesipour A
J Ethnopharmacol; 2006 Feb; 103(3):333-7. PubMed ID: 16213117
[TBL] [Abstract][Full Text] [Related]
10. Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice.
Bavarsad N; Fazly Bazzaz BS; Khamesipour A; Jaafari MR
Acta Trop; 2012 Oct; 124(1):33-41. PubMed ID: 22750480
[TBL] [Abstract][Full Text] [Related]
11. [Pain-relieving effect of cantharidin blister on lumbar spinal stenosis].
Rampp T; Michalsen A; Lüdtke R; Musial F; Kremer G; Dobos GJ
Forsch Komplementmed; 2009 Aug; 16(4):246-50. PubMed ID: 19729935
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of components from leaves of Calophyllum brasiliense against Leishmania (Leishmania) amazonensis.
Honda PA; Ferreira IC; Cortez DA; Amado CA; Silveira TG; Brenzan MA; Lonardoni MV
Phytomedicine; 2010 Apr; 17(5):333-8. PubMed ID: 19800777
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Trypan: a diminazene based drug as antileishmanial agent.
Macharia JC; Bourdichon AJ; Gicheru MM
Acta Trop; 2004; 92(3):267-72. PubMed ID: 15533297
[TBL] [Abstract][Full Text] [Related]
14. Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod.
El-On J; Bazarsky E; Sneir R
Exp Parasitol; 2007 Jun; 116(2):156-62. PubMed ID: 17306255
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection.
Pereira WK; Lonardoni MV; Grespan R; Caparroz-Assef SM; Cuman RK; Bersani-Amado CA
J Infect; 2005 Aug; 51(2):157-64. PubMed ID: 16038768
[TBL] [Abstract][Full Text] [Related]
16. Leishmania major and Leishmania tropica: I the in vitro effects of an immunomodulator, S2-Complex.
Al-Mulla Hummadi YM; Najim RA; Al-Bashir NM
Exp Parasitol; 2005 Sep; 111(1):47-54. PubMed ID: 15970286
[TBL] [Abstract][Full Text] [Related]
17. Effects of anti-Leishmania monoclonal antibodies on the development of Leishmania major in Phlebotomus duboscqi (Diptera: Psychodidae).
Anjili C; Langat B; Ngumbi P; Mbati PA; Githure J; Tonui WK
East Afr Med J; 2006 Feb; 83(2):72-8. PubMed ID: 16708877
[TBL] [Abstract][Full Text] [Related]
18. Detection of anti-leishmanial effect of the Lucilia sericata larval secretions in vitro and in vivo on Leishmania tropica: first work.
Polat E; Cakan H; Aslan M; Sirekbasan S; Kutlubay Z; Ipek T; Ozbilgin A
Exp Parasitol; 2012 Oct; 132(2):129-34. PubMed ID: 22750454
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 1alpha activity of peritoneal and bone marrow macrophages infected with Leishmania major and Leishmania donovani in vitro.
Bersudsky M; Apte RN; El-On J
Exp Parasitol; 2000 Mar; 94(3):150-7. PubMed ID: 10831379
[TBL] [Abstract][Full Text] [Related]
20. Activity of a paromomycin hydrophilic formulation for topical treatment of infections by Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
Gonçalves GS; Fernandes AP; Souza RC; Cardoso JE; de Oliveira-Silva F; Maciel FC; Rabello A; Ferreira LA
Acta Trop; 2005 Feb; 93(2):161-7. PubMed ID: 15652330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
